Progress of traditional Chinese medicine in the mult-drug resistance reversal of breast cancer

Abstract

GUO Xiao-Fei, LU Dan. Progress of traditional Chinese medicine in the mult-drug resistance reversal of breast cancer[J]. Journal of International Oncology, 2014, 41(3): 200-202.

［1］ Shi RZ,Li W, Zhang XL, et al.A novel indirubin derivative PHII7 potentiates adriamycin cyotoxicity via inhibiting Pglycoprotein expression in human breast cancer MCF7/ADR cells［J］. Eur J Pharmacol， 2011, 669(13):3844. ［2］ Choi JS, Piao YJ, Kang KW. Effects of quercetin on the bioavailability of doxorubicin in bats:roles of CYP3A4 and Pgp inhibition by quercetin［J］. Arch Pharm Res, 2011, 34(4):607613. ［3］ Ning W, Sun H, Wang FP, et al. H1,a novel derivative of tetrandrine reverse Pglycoproteinmediated multidrug resistance by inhibiting transport function and expression of Pglycoprotein［J］. Cancer Chemother Pharmacol, 2011, 67(5):10171025. ［4］ Lei Y, Tan J, Michael W, et al. An isoquinoline alkaloid from the Chinese herbal plant Corydalis yanhusuo W.T.Wang inhibits Pglycoprotein and multidrug resistanceassociate protein 1［J］. Food Chem, 2013, 136(4):11171121. ［5］Tran TP, Kim HG, Choi JH, et al. Reversal of Pglycoproteinmediated multidrug resistance is induced by mollugin in MCF7/adriamycin cells［J］. Phytomedicine, 2013, 20(7):622631. ［6］张晔，曲秀娟，刘云鹏，等. β榄香烯对人胃癌SGC7901/Adr细胞ERK通路的活化和GSTπ表达的影响［J］. 世界华人消化杂志， 2011, 19(13):13941397. ［7］汤涛，蒙凌华，陈凌际, 等. 鸦胆子油具有多药耐药逆转和拓扑异构酶Ⅱ抑制作用［J］. 药理学通报， 2001, 17（5）:534539. ［8］高娜，茹俊卿，张青. 中药逆转白血病多药耐药研究进展［J］. 江苏中医药, 2007, 39(3):6062. ［9］邓晓慧，宋海岩，张东军. 槲皮素对乳腺癌细胞增殖及Survivin表达的影响［J］. 中国医院药学杂志, 2013, 33(12):965967. ［10］邓晓慧，宋海岩, 孙春莉. 槲皮素对人卵巢癌SKOV3细胞增殖的影响［J］. 中国病理生理杂志, 2013, 29（1）:99102. ［11］周阿成，金黑鹰，张春霞. 槲皮素对结直肠癌作用及其机制的研究进展［J］.世界华人消化杂志, 2013， 19（9）：936939. ［12］张玉洁，曹军华，吴倩, 等. 槲皮素对人肝癌SMMC7721细胞增殖和凋亡及其凋亡通路的影响［J］. 中医药导报, 2013, 19(5):9395. ［13］ Dou J, Ying GG, Wang GW, et al. Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl2 and Bax regulation［J］. Mol Med Rep, 2012, 5(6):14531456. ［14］ Shan JZ, Xuan YY, Ruan SQ, et al. Proliferationinhibiting and apoptosisinducing effects of ursolic acid and oleanolic acid on multidrug resistance cancer cells in vitro［J］. Chin J Integr Med, 2011, 17(8):607611. ［15］ Zhu LT, Zhao L, Wang H, et al. OroxylinA reversePglycoproteinmediated multidrug resistance of MCF7/ADR cells by G2/M arrest［J］. Toxicol Lett, 2013, 219(2):107115. ［16］胡保全，唐鹏，齐晓伟, 等. 槐耳清膏对乳腺癌细胞系SUM159细胞干性特征的影响［J］. 第三军医大学学报, 2013, 35(11):11071110. ［17］ Mai TT, Moon J, Song Y, et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells［J］. Cancer Lett, 2012, 321(2):144153. ［18］ Zhou B, Xiao XL, Xu LL, et al. A dynamic study on reversal of multidrug resistance by ginsenoside Rh2 inadriamycinresistant human breast cancer MCF7 cells［J］. Talanta, 2012, 15 (88):345351. ［19］刘观昌，赵家坤，刘诚. 金雀异黄素对人乳腺癌细胞体外增殖作用机制的研究［J］. 中国煤炭工业医学杂志, 2011, 14（10）：15161519. ［20］ Fu JM, Zhou J, Shi J, et al. Emodin affects ERCC1 expression in breast cancer［J］. J Transl Med， 2012，10Suppl 1:S7.

[1]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[3]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.
[4]	Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190.
[5]	Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82.
[6]	Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer： present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58.
[7]	Wang Jing, Xu Wenting.Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526.
[8]	Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531.
[9]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456.
[10]	Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462.
[11]	An Rong, Liu Meihua, Wang Peichen, Wang Xiaohui.Research progress of Nrf2 in ovarian cancer[J]. Journal of International Oncology, 2023, 50(8): 493-497.
[12]	Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356.
[13]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[14]	Zhu Jun, Huang Meijin, Li Yuan, Liu Zegang, Xun Xin, Chen Hong.Research progress on targeted therapy of breast cancer with low expression of HER2[J]. Journal of International Oncology, 2023, 50(4): 236-240.
[15]	Zhou Ting, Xu Shaohua, Mei Lin.Efficacy and safety of bevacizumab combined with capecitabine in the treatment of advanced breast cancer[J]. Journal of International Oncology, 2023, 50(3): 144-149.

Progress of traditional Chinese medicine in the mult-drug resistance reversal of breast cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments